Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
586-600 of 2992 results
Roche and Global Fund partner for HIV diagnostic technologies
By MDBR Staff Writer
Switzerland-based Roche has agreed to provide HIV-1 viral load and early infant diagnostic technologies for the Global Fund.
Diagnostics > In Vitro Diagnostics > News
Hill-Rom to buy Welch Allyn for $2.05bn
By MDBR Staff Writer
Medical technology firm Hill-Rom Holdings has signed an agreement to acquire US-based Welch Allyn, for around $2.05bn in cash and stock.
Diagnostics > In Vitro Diagnostics > News
handyem and FlowMetric Diagnostics announce partnership in development of flow cytometry-based solutions in diagnostic capabilities
By MDBR Staff Writer
handyem and FlowMetric Diagnostics announce their partnership centralized around the incorporation of handyem's HPC-150 portable flow cytometer within FlowMetric Diagnostics' mobile point-of-care diagnostic laboratory, the Mo-POD.
Diagnostics > In Vitro Diagnostics > News
Castle Biosciences announces national payer agreements with MultiPlan, FedMed and Preferred Medical Claim Solutions
By MDBR Staff Writer
Castle Biosciences, a provider of molecular diagnostics to improve cancer treatment decisions, today announced the Company has secured payer contracts with national provider networks MultiPlan, FedMed and Preferred Medical Claim Solutions to provide coverage of its DecisionDx assays.
Diagnostics > In Vitro Diagnostics > News
Quanterix names PBL Assay Science as preferred partner in assay development and testing services
By MDBR Staff Writer
Quanterix , a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced an alliance with PBL Assay Science (PBL), naming the Company as a Preferred Partner for assay research and development.
Diagnostics > In Vitro Diagnostics > News
BioLight and Ora to develop TeaRx diagnostic test for dry eye syndrome
By MDBR Staff Writer
BioLight Life Sciences Investments has entered into a collaboration agreement with Ora to enhance the clinical, regulatory and commercial development of its TeaRx multi-parameter diagnostic test for dry eye syndrome (DES).
Diagnostics > In Vitro Diagnostics > News
Ventana ALK CDx assay obtains FDA approval to identify lung cancer patients
By MDBR Staff Writer
Roche Group subsidiary Ventana Medical Systems has received approval from the US Food and Drug Administration (FDA) for its ALK (D5F3) CDx assay for use as a companion diagnostic to identify lung cancer patients for Pfizer's FDA approved targeted therapy Xalkori (crizotinib).
Diagnostics > In Vitro Diagnostics > News
OraSure receives HHS contract to develop its rapid Ebola test
By MDBR Staff Writer
OraSure Technologies has received a $10.4m contract to advance the clinical development of its OraQuick Ebola rapid antigen test.
Diagnostics > In Vitro Diagnostics > News
Asuragen announces launch of CE-IVD BCR-ABL assay
By MDBR Staff Writer
Asuragen announced the commercial launch of its CE-IVD Quantidex BCR-ABL IS CMR Kit for monitoring BCR-ABL1 transcript levels in patients with Chronic Myeloid Leukemia (CML).
Diagnostics > In Vitro Diagnostics > News
BioNTech introduces MammaTyper breast cancer diagnostic test in Europe
By MDBR Staff Writer
BioNTech, along with its subsidiary BioNTech Diagnostics, announced that it has introduced CE-IVD marked breast cancer diagnostic test, MammaTyper, in the Europe.
Diagnostics > In Vitro Diagnostics > News
Sebia’s Capillarys 3 Tera receives CE mark approval for HbA1c and serum protein testing
Sebia has received CE mark approval for Capillarys 3 Tera to use for HbA1c and serum protein testing and immunotyping.
Diagnostics > In Vitro Diagnostics > News
InDevR introduces new Cypher One hemagglutination analysis system
By MDBR Staff Writer
Life science firm InDevR has introduced new hemagglutination analysis system, Cypher One, which will allow to improve vaccine characterization.
Diagnostics > In Vitro Diagnostics > News
Linkage Biosciences announces CE Mark for real-time PCR HLA Test
By MDBR Staff Writer
Linkage Biosciences, a global leader in the field of transplant diagnostics, announced that the LinkSēq Human Leukocyte Antigen (HLA) test is now available with CE mark.
Diagnostics > In Vitro Diagnostics > News
Roche to develop companion diagnostic for DalCor’s therapeutic
By MDBR Staff Writer
Switzerland-based Roche has signed an agreement to develop a companion diagnostic (CDx) test for DalCor Pharmaceuticals’ therapeutic dalcetrapib.
Diagnostics > In Vitro Diagnostics > News
Luminex starts Aries GBS assay clinical trials
By MDBR Staff Writer
Luminex has started clinical and analytical trials to assess its Aries Group B Streptococcus (GBS) assay.
Diagnostics > In Vitro Diagnostics > News
586-600 of 2992 results